These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33767451)

  • 1. Scaling analysis reveals the mechanism and rates of prion replication in vivo.
    Meisl G; Kurt T; Condado-Morales I; Bett C; Sorce S; Nuvolone M; Michaels TCT; Heinzer D; Avar M; Cohen SIA; Hornemann S; Aguzzi A; Dobson CM; Sigurdson CJ; Knowles TPJ
    Nat Struct Mol Biol; 2021 Apr; 28(4):365-372. PubMed ID: 33767451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Carlson GA; Prusiner SB
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
    Marrero-Winkens C; Sankaran C; Schätzl HM
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular processes underpinning prion-like spreading and seed amplification in protein aggregation.
    Meisl G; Knowles TP; Klenerman D
    Curr Opin Neurobiol; 2020 Apr; 61():58-64. PubMed ID: 32092527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
    Moreno-Gonzalez I; Soto C
    Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into Mechanisms of Chronic Neurodegeneration.
    Diack AB; Alibhai JD; Barron R; Bradford B; Piccardo P; Manson JC
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intercellular Spread of Protein Aggregates in Neurodegenerative Disease.
    Davis AA; Leyns CEG; Holtzman DM
    Annu Rev Cell Dev Biol; 2018 Oct; 34():545-568. PubMed ID: 30044648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage M13 for the treatment of Alzheimer and Parkinson disease.
    Messing J
    Gene; 2016 Jun; 583(2):85-89. PubMed ID: 26869319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease.
    Pearce MM
    Curr Opin Genet Dev; 2017 Jun; 44():149-155. PubMed ID: 28441621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation.
    Tarutani A; Suzuki G; Shimozawa A; Nonaka T; Akiyama H; Hisanaga S; Hasegawa M
    J Biol Chem; 2016 Sep; 291(36):18675-88. PubMed ID: 27382062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
    Goedert M
    Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
    Lloyd GM; Dhillon JS; Gorion KM; Riffe C; Fromholt SE; Xia Y; Giasson BI; Borchelt DR
    Mol Neurodegener; 2021 Sep; 16(1):63. PubMed ID: 34503546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of prion-like transfer in Huntington's disease models.
    Jansen AH; Batenburg KL; Pecho-Vrieseling E; Reits EA
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):793-800. PubMed ID: 28040507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transmission of pathogenic protein aggregates in Alzheimer's disease].
    Schwarzman AL; Sarantseva SV
    Mol Biol (Mosk); 2017; 51(3):418-422. PubMed ID: 28707657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice.
    Johnson NR; Condello C; Guan S; Oehler A; Becker J; Gavidia M; Carlson GA; Giles K; Prusiner SB
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11029-E11036. PubMed ID: 29203673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence features governing aggregation or degradation of prion-like proteins.
    Cascarina SM; Paul KR; Machihara S; Ross ED
    PLoS Genet; 2018 Jul; 14(7):e1007517. PubMed ID: 30005071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein.
    Hardy J
    Neurosci Lett; 1994 Oct; 180(2):290-1. PubMed ID: 7700596
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.
    Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.